Beyond Barriers Therapeutics
Introductions
Traumatic Brain Injury:
Every 15 seconds an American suffers a Traumatic Brain Injury (TBI), and many people are left with lasting cognitive and functional deficits for months or even years after injury. Despite a significant need, no current specific pharmacological therapies exist for TBI; Beyond Barriers Therapeutics aims to change this.
Our Vision:
Our vision is to move groundbreaking science from the laboratory into the clinic. We are thrilled to have entered the third phase of the Neuro Startup Competition as it has started us on the path towards finding new specific therapeutics that target inflammation and decrease the impact of injury following TBI.
Our Plan:
We have officially incorporated this month and have been working hard to connect with potential partners in the industry. We are also currently assembling an advisory board, searching for funding opportunities, and refining our business plan. We are excited to continue to collaborate with the Center for Advancing Innovation, the National Institutes of Health and our partners at Northwestern University.
Beyond Barriers Therapeutics is passionate about its mission to transform cutting edge basic science into a novel product for treating inflammation following TBI.
Every 15 seconds an American suffers a Traumatic Brain Injury (TBI), and many people are left with lasting cognitive and functional deficits for months or even years after injury. Despite a significant need, no current specific pharmacological therapies exist for TBI; Beyond Barriers Therapeutics aims to change this.
Our Vision:
Our vision is to move groundbreaking science from the laboratory into the clinic. We are thrilled to have entered the third phase of the Neuro Startup Competition as it has started us on the path towards finding new specific therapeutics that target inflammation and decrease the impact of injury following TBI.
Our Plan:
We have officially incorporated this month and have been working hard to connect with potential partners in the industry. We are also currently assembling an advisory board, searching for funding opportunities, and refining our business plan. We are excited to continue to collaborate with the Center for Advancing Innovation, the National Institutes of Health and our partners at Northwestern University.
Beyond Barriers Therapeutics is passionate about its mission to transform cutting edge basic science into a novel product for treating inflammation following TBI.
